The Enhanced Liver Fibrosis (ELF) Test from Siemens Healthineers is now available in the United States, providing broad clinical access to the minimally invasive prognostic tool. Currently, the ELF ...
Disclaimer: The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed. In the U.S., the ELF Test is indicated as a ...
Siemens is launching its Enhanced Liver Fibrosis (ELF) diagnostic in the U.S. this week to help test patients with chronic liver disease. This new testing service comes out of the Siemens Healthcare ...
At present, transient elastography and the serum marker FibroTest are the most intensively evaluated non-invasive methods for the assessment of liver fibrosis. The results of the present study for ...
BURLINGTON, N.C.--(BUSINESS WIRE)--For the millions of people in the United States living with an advanced form of chronic liver disease, simply understanding the potential for future complications ...
The study period for sample acquisition was from September 2005 to June 2008. The Serum bank of the J.W. Goethe-University Hospital was checked for serum of patients with chronic liver disease, who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results